These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

208 related articles for article (PubMed ID: 26910383)

  • 41. Chlorambucil and cyclosporine A in Brazilian patients with Behçet's disease uveitis: a retrospective study.
    Zaghetto JM; Yamamoto MM; Souza MB; Silva FT; Hirata CE; Olivalves E; Yamamoto JH
    Arq Bras Oftalmol; 2010; 73(1):40-6. PubMed ID: 20464112
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Anakinra for resistant Behçet uveitis: why not?
    Emmi G; Silvestri E; Cameli AM; Bacherini D; Vannozzi L; Squatrito D; Emmi L
    Clin Exp Rheumatol; 2013; 31(3 Suppl 77):152-3. PubMed ID: 24064028
    [No Abstract]   [Full Text] [Related]  

  • 43. Intravitreal Dexamethasone Implant for Treatment of Refractory Behçet Posterior Uveitis: One-year Follow-up Results.
    Coşkun E; Celemler P; Kimyon G; Öner V; Kisacik B; Erbagci I; Onat AM
    Ocul Immunol Inflamm; 2015; 23(6):437-43. PubMed ID: 26470764
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Efficacy of Infliximab for Early Remission Induction in Refractory Uveoretinitis Associated with Behçet Disease: A 2-year Follow-up Study.
    Keino H; Okada AA; Watanabe T; Nakayama M; Nakamura T
    Ocul Immunol Inflamm; 2017 Feb; 25(1):46-51. PubMed ID: 27767359
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Long-term remission after cessation of interferon-α treatment in patients with severe uveitis due to Behçet's disease.
    Deuter CM; Zierhut M; Möhle A; Vonthein R; Stöbiger N; Kötter I
    Arthritis Rheum; 2010 Sep; 62(9):2796-805. PubMed ID: 20518075
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Long-term clinical outcomes in patients with refractory uveitis associated with Behçet disease treated with infliximab.
    Al Rashidi S; Al Fawaz A; Kangave D; Abu El-Asrar AM
    Ocul Immunol Inflamm; 2013 Dec; 21(6):468-74. PubMed ID: 23734940
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Effectiveness of Infliximab and Interferon Alpha-2a for the Treatment of Behçet's Uveitis: Customizing Therapy according to the Clinical Features.
    De Simone L; Invernizzi A; Aldigeri R; Mastrofilippo V; Marvisi C; Gozzi F; Bolletta E; Adani C; Pipitone N; Muratore F; Fontana L; Salvarani C; Cimino L
    Ocul Immunol Inflamm; 2022 Feb; 30(2):506-514. PubMed ID: 33021421
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Combined cyclosporine and corticosteroid therapy for sight-threatening uveitis in Behçet's disease.
    Whitcup SM; Salvo EC; Nussenblatt RB
    Am J Ophthalmol; 1994 Jul; 118(1):39-45. PubMed ID: 8023874
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Clinical Follow-up of Patients with Behçet Uveitis after Discontinuation of Infliximab Therapy.
    Köse HC; Yalçındağ N
    Ocul Immunol Inflamm; 2022 Jan; 30(1):203-207. PubMed ID: 32779960
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Successful Treatment with Infliximab for Refractory Uveitis in a Hemodialysis Patient with Behçet's Disease and a Review of the Literature for Infliximab Use in Patients on Hemodialysis.
    Kurata I; Tsuboi H; Takahashi H; Abe S; Ebe H; Hagiwara S; Umeda N; Kondo Y; Ogishima H; Suzuki T; Matsumoto I; Hoshi S; Oshika T; Sumida T
    Intern Med; 2015; 54(12):1553-7. PubMed ID: 26073249
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Treatment of Adamantiades-Behçet disease with systemic interferon alfa.
    Zouboulis CC; Orfanos CE
    Arch Dermatol; 1998 Aug; 134(8):1010-6. PubMed ID: 9722733
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Fluorescein angiography and visual acuity in active uveitis with Behçet disease.
    Yu HG; Kim MJ; Oh FS
    Ocul Immunol Inflamm; 2009; 17(1):41-6. PubMed ID: 19294573
    [TBL] [Abstract][Full Text] [Related]  

  • 53. [Effectiveness of interferon alpha in the treatment of uveitis macular edema refractory to corticosteroid and/or immunosuppressive treatment].
    Paire V; Lebreton O; Weber M
    J Fr Ophtalmol; 2010 Mar; 33(3):152-62. PubMed ID: 20181409
    [TBL] [Abstract][Full Text] [Related]  

  • 54. [The short-term efficacy and safety treatment study of recurrent uveitis in Behcet disease with etanercept].
    Zhang MF; Zhao C; Wen X; Du H; Zhao Y
    Zhonghua Yan Ke Za Zhi; 2010 Feb; 46(2):145-50. PubMed ID: 20388349
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Short-term chlorambucil for refractory uveitis in Behcet's disease.
    Mudun BA; Ergen A; Ipcioglu SU; Burumcek EY; Durlu Y; Arslan MO
    Ocul Immunol Inflamm; 2001 Dec; 9(4):219-29. PubMed ID: 11935432
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Long-Term Efficacy and Safety of Interferon Alpha-2a in the Treatment of Chinese Patients with Behçet's Uveitis Not Responding to Conventional Therapy.
    Yang P; Huang G; Du L; Ye Z; Hu K; Wang C; Qi J; Liang L; Wu L; Cao Q; Kijlstra A
    Ocul Immunol Inflamm; 2019; 27(1):7-14. PubMed ID: 29040035
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Long-term efficacy and safety of interferon α-2a therapy in severe refractory ophthalmic Behcet's disease.
    Kavandi H; Khabbazi A; Kolahi S; Hajialilo M; Shayan FK; Oliaei M
    Clin Rheumatol; 2016 Nov; 35(11):2765-2769. PubMed ID: 27234230
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Immunosuppressive treatment in refractory chronic inflammatory demyelinating polyradiculoneuropathy. A nationwide retrospective analysis.
    Cocito D; Grimaldi S; Paolasso I; Falcone Y; Antonini G; Benedetti L; Briani C; Fazio R; Jann S; Matà S; Sabatelli M; Nobile-Orazio E;
    Eur J Neurol; 2011 Dec; 18(12):1417-21. PubMed ID: 21819489
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Does lowering hyperhomocysteinemia by folic acid beneficial for oculo-Behcet's disease? A pilot study.
    Houman MH; Naffati H; Khanfir M; Ghannouchi M; Ben Ghorbel I; Lamloum M; El Matri L; Hamzaoui K; Jeddi A; Miled M; Fki M
    Tunis Med; 2007 Jun; 85(6):450-3. PubMed ID: 17644895
    [TBL] [Abstract][Full Text] [Related]  

  • 60. [The treatment of recurrent uveitis with TNF-alpha inhibitors].
    Falappone PC; Iannone F; Scioscia C; Grattagliano V; Covelli M; Lapadula G
    Reumatismo; 2004; 56(3):185-9. PubMed ID: 15470524
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.